SARS-CoV-2 S2P spike ages through distinct states with altered immunogenicity

J Biol Chem. 2021 Oct;297(4):101127. doi: 10.1016/j.jbc.2021.101127. Epub 2021 Aug 27.

Abstract

The SARS-CoV-2 spike is the primary target of virus-neutralizing antibodies and critical to the development of effective vaccines against COVID-19. Here, we demonstrate that the prefusion-stabilized two-proline "S2P" spike-widely employed for laboratory work and clinical studies-unfolds when stored at 4 °C, physiological pH, as observed by electron microscopy (EM) and differential scanning calorimetry, but that its trimeric, native-like conformation can be reacquired by low pH treatment. When stored for approximately 1 week, this unfolding does not significantly alter antigenic characteristics; however, longer storage diminishes antibody binding, and month-old spike elicits virtually no neutralization in mice despite inducing high ELISA-binding titers. Cryo-EM structures reveal the folded fraction of spike to decrease with aging; however, its structure remains largely similar, although with varying mobility of the receptor-binding domain. Thus, the SARS-CoV-2 spike is susceptible to unfolding, which affects immunogenicity, highlighting the need to monitor its integrity.

Keywords: COVID-19 vaccine; S2P; SARS-CoV-2 spike; pH-induced folding; unfolding.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, N.I.H., Intramural

MeSH terms

  • Animals
  • Antibodies, Neutralizing / immunology
  • Antigen-Antibody Reactions
  • COVID-19 / pathology
  • COVID-19 / virology
  • Calorimetry, Differential Scanning
  • Cryoelectron Microscopy
  • Female
  • Humans
  • Hydrogen-Ion Concentration
  • Mice
  • Mice, Inbred BALB C
  • Protein Structure, Tertiary
  • Protein Unfolding
  • SARS-CoV-2 / isolation & purification
  • SARS-CoV-2 / metabolism*
  • Spike Glycoprotein, Coronavirus / chemistry
  • Spike Glycoprotein, Coronavirus / immunology*
  • Spike Glycoprotein, Coronavirus / metabolism
  • Time Factors

Substances

  • Antibodies, Neutralizing
  • Spike Glycoprotein, Coronavirus
  • spike protein, SARS-CoV-2